Literature DB >> 17072979

Attenuation of dextran sodium sulphate induced colitis in matrix metalloproteinase-9 deficient mice.

Alfredo Santana1, Carlos Medina, Maria-Cristina Paz-Cabrera, Federico Díaz-Gonzalez, Esther Farré, Antonio Salas, Marek-W Radomski, Enrique Quintero.   

Abstract

AIM: To study whether matrix metalloproteinase-9 (MMP-9) is a key factor in epithelial damage in the dextran sodium sulphate (DSS) model of colitis in mice.
METHODS: MMP-9-deficient and wild-type (wt) mice were given 5% DSS in drinking water for 5 d followed by recovery up to 7 d. On d 5 and 12 after induction of colitis, gelatinases, MMP-2 and MMP-9, were measured in homogenates of colonic tissue by zymography and Western blot, whereas tissue inhibitor of metalloproteinases (TIMPs) were measured by reverse zymography. The gelatinolytic activity was also determined in supernatants of polymorphonuclear leukocytes (PMN) isolated from mice blood. Moreover, intestinal epithelial cells were stimulated with TNF-alpha to study whether these cells were able to produce MMPs. Finally, colonic mucosal lesions were measured by microscopic examination.
RESULTS: On d 5 of colitis, the activity of MMP-9 was increased in homogenates of colonic tissues (0.24+/-0.1 vs 21.3+/-6.4, P<0.05) and PMN from peripheral blood in wt (0.5+/-0.1 vs 10.4+/-0.7, P<0.05), but not in MMP-9-deficient animals. The MMP-9 activity was also up-regulated by TNF-alpha in epithelial intestinal cells (2.5+/-0.5 vs 14.7+/-3.0, P<0.05). Although colitis also led to increase of TIMP-1 activity, the MMP-9/TIMP-1 balance remained elevated. Finally, in the MMP-9-deficient colitic mice both the extent and severity of intestinal epithelial injury were significantly attenuated when compared with wt mice.
CONCLUSION: We conclude that DSS induced colitis is markedly attenuated in animals lacking MMP-9. This suggests that intestinal injury induced by DSS is modulated by MMP-9 and that inhibition of this gelatinase may reduce inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17072979      PMCID: PMC4100636          DOI: 10.3748/wjg.v12.i40.6464

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  39 in total

1.  Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis.

Authors:  A Stallmach; C C Chan; K W Ecker; G Feifel; H Herbst; D Schuppan; M Zeitz
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

2.  The role of up-regulated serine proteases and matrix metalloproteinases in the pathogenesis of a murine model of colitis.

Authors:  J F Tarlton; C V Whiting; D Tunmore; S Bregenholt; J Reimann; M H Claesson; P W Bland
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

3.  Matrix metalloproteinase levels are elevated in inflammatory bowel disease.

Authors:  M D Baugh; M J Perry; A P Hollander; D R Davies; S S Cross; A J Lobo; C J Taylor; G S Evans
Journal:  Gastroenterology       Date:  1999-10       Impact factor: 22.682

4.  The effect of an inhibitor of matrix metalloproteinases on colonic inflammation in a trinitrobenzenesulphonic acid rat model of inflammatory bowel disease.

Authors:  A P Sykes; R Bhogal; C Brampton; C Chander; C Whelan; M E Parsons; J Bird
Journal:  Aliment Pharmacol Ther       Date:  1999-11       Impact factor: 8.171

5.  A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response.

Authors:  C G Su; X Wen; S T Bailey; W Jiang; S M Rangwala; S A Keilbaugh; A Flanigan; S Murthy; M A Lazar; G D Wu
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

6.  Matrix metalloproteinases: biologic activity and clinical implications.

Authors:  A R Nelson; B Fingleton; M L Rothenberg; L M Matrisian
Journal:  J Clin Oncol       Date:  2000-03       Impact factor: 44.544

7.  Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease.

Authors:  R B Heuschkel; T T MacDonald; G Monteleone; M Bajaj-Elliott; J A Smith; S L Pender
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

8.  Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease.

Authors:  B von Lampe; B Barthel; S E Coupland; E O Riecken; S Rosewicz
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

9.  Suppression of T cell-mediated injury in human gut by interleukin 10: role of matrix metalloproteinases.

Authors:  S L Pender; E J Breese; U Günther; D Howie; N C Wathen; D Schuppan; T T MacDonald
Journal:  Gastroenterology       Date:  1998-09       Impact factor: 22.682

10.  The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia-induced lung injury in newborn rats.

Authors:  A Radomski; G Sawicki; D M Olson; M W Radomski
Journal:  Br J Pharmacol       Date:  1998-12       Impact factor: 8.739

View more
  40 in total

1.  Hyperhomocysteinemia decreases intestinal motility leading to constipation.

Authors:  S Givvimani; C Munjal; N Narayanan; F Aqil; G Tyagi; N Metreveli; S C Tyagi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-05-17       Impact factor: 4.052

2.  Notch1 regulates the effects of matrix metalloproteinase-9 on colitis-associated cancer in mice.

Authors:  Pallavi Garg; Sabrina Jeppsson; Guillaume Dalmasso; Amr M Ghaleb; Beth B McConnell; Vincent W Yang; Andrew T Gewirtz; Didier Merlin; Shanthi V Sitaraman
Journal:  Gastroenterology       Date:  2011-06-30       Impact factor: 22.682

3.  Inhibition of matrix metalloproteinase-9 by a barbiturate-nitrate hybrid ameliorates dextran sulphate sodium-induced colitis: effect on inflammation-related genes.

Authors:  Shane O'Sullivan; Jun Wang; Maria T Pigott; Neil Docherty; Noreen Boyle; Samuel Kana Lis; John F Gilmer; Carlos Medina
Journal:  Br J Pharmacol       Date:  2017-02-24       Impact factor: 8.739

4.  Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis.

Authors:  Prashant Nighot; Rana Al-Sadi; Manmeet Rawat; Shuhong Guo; D Martin Watterson; Thomas Ma
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-10-29       Impact factor: 4.052

5.  Matrix metalloproteinase-9 inhibition reduces inflammation and improves motility in murine models of postoperative ileus.

Authors:  Beverley A Moore; Carl L Manthey; Dana L Johnson; Anthony J Bauer
Journal:  Gastroenterology       Date:  2011-06-22       Impact factor: 22.682

6.  Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis.

Authors:  Pallavi Garg; Matam Vijay-Kumar; Lixin Wang; Andrew T Gewirtz; Didier Merlin; Shanthi V Sitaraman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-02       Impact factor: 4.052

Review 7.  Digestive Inflammation: Role of Proteolytic Dysregulation.

Authors:  Vincent Mariaule; Aicha Kriaa; Souha Soussou; Soufien Rhimi; Houda Boudaya; Juan Hernandez; Emmanuelle Maguin; Adam Lesner; Moez Rhimi
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

8.  WGCNA Reveals Key Roles of IL8 and MMP-9 in Progression of Involvement Area in Colon of Patients with Ulcerative Colitis.

Authors:  Xue Lin; Jin Li; Qiu Zhao; Jue-Rong Feng; Qian Gao; Jia-Yan Nie
Journal:  Curr Med Sci       Date:  2018-04-30

Review 9.  Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems.

Authors:  Kristina K Hansen; Katerina Oikonomopoulou; Yang Li; Morley D Hollenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-10-19       Impact factor: 3.000

10.  MMP9 is protective against lethal inflammatory mass lesions in the mouse colon.

Authors:  Andreas Hald; Birgitte Rønø; Maria C Melander; Ming Ding; Susanne Holck; Leif R Lund
Journal:  Dis Model Mech       Date:  2010-12-01       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.